1-9 of 9
Michael T. Schweizer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1

Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa, Jose Angel Arranz Arija, Emeline Colomba, Gwenaelle Gravis, Loic Mourey, Stephane Oudard, Aude Fléchon, Macarena González, Pablo M. Rey, Michael T. Schweizer, Enrique Gallardo, Erica Johnston, Arjun Balar, Nadine Haddad, Adams K. Appiah, Karim Nacerddine, José M. Piulats
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (11): 2377–2383.
https://doi.org/10.1158/1078-0432.CCR-23-3436
Published: 03 June 2024
View article titled, A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1
Open the PDF for A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1 in another window
Includes: Supplementary data
Journal Articles

Hypermutation, Mismatch Repair Deficiency, and Defining Predictors of Response to Checkpoint Blockade

Laura S. Graham, Colin C. Pritchard, Michael T. Schweizer
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6662–6665.
https://doi.org/10.1158/1078-0432.CCR-21-3031
Published: 15 December 2021
View article titled, Hypermutation, Mismatch Repair Deficiency, and Defining Predictors of Response to Checkpoint Blockade
Open the PDF for Hypermutation, Mismatch Repair Deficiency, and Defining Predictors of Response to Checkpoint Blockade in another window
Journal Articles

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

Elahe A. Mostaghel, Brett T. Marck, Orpheus Kolokythas, Felix Chew, Evan Y. Yu, Michael T. Schweizer, Heather H. Cheng, Phillip W. Kantoff, Steven P. Balk, Mary-Ellen Taplin, Nima Sharifi, Alvin M. Matsumoto, Peter S. Nelson, R. Bruce Montgomery
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (21): 6001–6011.
https://doi.org/10.1158/1078-0432.CCR-21-1819
Published: 01 November 2021
View article titled, Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer
Open the PDF for Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer

Diana C. DeLucia, Thomas M. Cardillo, Lisa Ang, Mark P. Labrecque, Ailin Zhang, James E. Hopkins, Navonil De Sarkar, Ilsa Coleman, Rui M. Gil da Costa, Eva Corey, Lawrence D. True, Michael C. Haffner, Michael T. Schweizer, Colm Morrissey, Peter S. Nelson, John K. Lee
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (3): 759–774.
https://doi.org/10.1158/1078-0432.CCR-20-3396
Published: 01 February 2021
View article titled, Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer
Open the PDF for Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Rahul R. Aggarwal, Michael T. Schweizer, David M. Nanus, Allan J. Pantuck, Elisabeth I. Heath, Eric Campeau, Sarah Attwell, Karen Norek, Margo Snyder, Lisa Bauman, Sanjay Lakhotia, Felix Y. Feng, Eric J. Small, Wassim Abida, Joshi J. Alumkal
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5338–5347.
https://doi.org/10.1158/1078-0432.CCR-20-1707
Published: 15 October 2020
View article titled, A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Open the PDF for A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer

Christos E. Kyriakopoulos, Jens C. Eickhoff, Anna C. Ferrari, Michael T. Schweizer, Ellen Wargowski, Brian M. Olson, Douglas G. McNeel
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (19): 5162–5171.
https://doi.org/10.1158/1078-0432.CCR-20-0945
Published: 01 October 2020
View article titled, Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer
Open the PDF for Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PR06: Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

Brian R. Winters, Navonil De Sarkar, Sonali Arora, Hamid Bolouri, Sujata Jana, Funda Vakar-Lopez, Heather H. Cheng, Michael T. Schweizer, Evan Y. Yu, Petros Grivas, John K. Lee, Lori Kollath, Sarah K. Holt, Lisa McFerrin, Gavin Ha, Peter S. Nelson, Robert B. Montgomery, Jonathan L. Wright, Hung-Ming Lam, Andrew C. Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): PR06.
https://doi.org/10.1158/1557-3265.BLADDER19-PR06
Published: 03 August 2020
View article titled, Abstract PR06: Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Journal Articles

“Matching” the “Mismatch” Repair–Deficient Prostate Cancer with Immunotherapy

Michael T. Schweizer, Evan Y. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 981–983.
https://doi.org/10.1158/1078-0432.CCR-19-3780
Published: 02 March 2020
View article titled, “Matching” the “Mismatch” Repair–Deficient Prostate Cancer with Immunotherapy
Open the PDF for “Matching” the “Mismatch” Repair–Deficient Prostate Cancer with Immunotherapy in another window
Journal Articles

MSH2 Loss in Primary Prostate Cancer

Liana B. Guedes, Emmanuel S. Antonarakis, Michael T. Schweizer, Nooshin Mirkheshti, Fawaz Almutairi, Jong Chul Park, Stephanie Glavaris, Jessica Hicks, Mario A. Eisenberger, Angelo M. De Marzo, Jonathan I. Epstein, William B. Isaacs, James R. Eshleman, Colin C. Pritchard, Tamara L. Lotan
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (22): 6863–6874.
https://doi.org/10.1158/1078-0432.CCR-17-0955
Published: 14 November 2017
View article titled, MSH2 Loss in Primary Prostate Cancer
Open the PDF for MSH2 Loss in Primary Prostate Cancer in another window
Includes: Supplementary data